-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, EkKBXidz4DepA1zxjInxDdNzUczOoo6wNIeE2K3e3h09mKf4u3cvOdBgEqDYDEUK h39h8Z2w62mnZDQeZt3DfA== 0000950135-95-002266.txt : 19951031 0000950135-95-002266.hdr.sgml : 19951031 ACCESSION NUMBER: 0000950135-95-002266 CONFORMED SUBMISSION TYPE: 10-C PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19950927 FILED AS OF DATE: 19951030 SROS: NASD FILER: COMPANY DATA: COMPANY CONFORMED NAME: GENZYME CORP CENTRAL INDEX KEY: 0000732485 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 061047163 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-C SEC ACT: 1934 Act SEC FILE NUMBER: 000-14680 FILM NUMBER: 95585449 BUSINESS ADDRESS: STREET 1: ONE KENDALL SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6172527500 MAIL ADDRESS: STREET 1: ONE KENDALL SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 10-C 1 GENZYME CORPORATION 1 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-C Report by Issuer of Securities Quoted on NASDAQ Interdealer Quotation System Filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 and Rule 13a-17 or 15d-17 thereunder GENZYME CORPORATION - -------------------------------------------------------------------------------- (Exact name of issuer as specified in charter) One Kendall Square, Cambridge, Massachusetts 02139 - -------------------------------------------------------------------------------- (Address of principal executive offices) Issuer's telephone number, including area code: (617) 252-7500 ---------------- I. CHANGE IN NUMBER OF SHARES OUTSTANDING Indicate any change (increase or decrease) of 5% or more in the number of shares outstanding: 1. Title of Security: TISSUE REPAIR DIVISION COMMON STOCK, $0.01 PAR VALUE 2. Number of shares outstanding before the change: 8,818,362 AS OF JUNE 30, 1995 3. Number of shares outstanding after the change: 11,818,362 4. Effective date of change: SEPTEMBER 27, 1995 5. Method of change: Specify method (such as merger, acquisition, exchange, distribution, stock split, reverse split, acquisition of stock for treasury, etc.): PUBLIC OFFERING. Give brief description of transaction: (1) ISSUANCE OF 3,000,000 SHARES IN UNDERWRITTEN PUBLIC OFFERING, WITH AN ADDITIONAL 450,000 SHARES RESERVED FOR UNDERWRITERS' OVER-ALLOTMENTS. II. CHANGE IN NAME OF ISSUER Not Applicable Date: September 27, 1995 /s/ Evan M. Lebson ------------------------------------ Name: Evan M. Lebson Title: Vice President, Treasurer -----END PRIVACY-ENHANCED MESSAGE-----